Perspective · 21 Apr 2025
Conference abstractPublished 28 Jul 2014
Death receptor 5 (DR5) marks the highly pathogenic interacting GM-CSF+ T helper cells and IL-23+ macrophages rendering it as an attractive therapeutic target of Rheumatoid arthritis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T he highly pathogenic GM-CSF + IL-17 + CD4 T cells and IL-23 + IRF5 + M1 macrophages exhibit a bidirectional interaction in autoimmunity. Death receptor 5 (.alyzed DR5 expression and apoptosis function of an anti-human DR5 antibody, TRA-8, in macrophages and T cells in humans and humanized DR5 transgenic mice in the context of collagen II-induced arthritis (CIA) and systemic autoimmune diseases. Expression of DR5 was highly correlated with that of GM-CSF in CD4 T cells and that of IL-23 and IRF5 in macrophages from synovia fluid of Rheumatoid arthritis (RA) patients (p<0.01). In vitro treatment with TRA-8 resulted in 94.1% and 43.4% depletion of GM-CSF+ CD4+ T cells and IL-23 + macrophages, respectively. CIA was induced inhumanized DR5 transgenic mice (Tg + ). TRA-8 (0.2 mg/mouse) was I.V. weekly initiated on day 30 until mice were sacrificed 3-mo post CII. TRA-8 treatment resulted in a 60% reduction of CD11b + macrophages in the draining lymph nodes (LNs) of Tg + mice. Within the CD11b + cells, ~60% of the Ly6c + activated macrophages and ~90% of the IL-23 + macrophages were eliminated by TRA-8. The depletion also leads to elevation of CD4 + Foxp3 + Tregs (3.6% to 5.9%, P<0.05) and reduction of the CD4 + IL-17 + Th17 cells (1.4% to 0.6%, P<0.05). After TRA-8 treatment, joint histopathology showed a significantly decreased MAC3 + macrophage infiltration, synovial hyperplasia, and destruction (arthritis score: 9.8 versus 1.5, P<0.01). In DR5 transgenic mice crossed with the Shp-1 negative regulator deficient viable motheaten mice, 3 doses of TRA-8 (0.1 mg IP, weekly) lead to a 35.7% reduction of GM-CSF + CD4 + T cells and 45.1% reduction of IL-23 + IRF5 + macrophages in the draining LNs. TRA-8 treatment also decreased expression levels of Csf-2 and p19 by 74.4% and 94.7% respectively in joints. These findings were associated with amelioration of hemorrhagic pneumonitis and arthritis, reduction of autoantibodies, and increased lifespan in these mice. The study indicated that DR5 expression marks the GM-CSF + CD4 + T cells and IL- 23 + macrophages. We also demonstrated the high therapeutic efficacy of an anti-human DR5 antibody in arthritis and other autoimmune diseases.
Subjects
OrthopaedicsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Orthopedic & Muscular System: Current Research.
Perspective · 21 Apr 2025
Comprehensive Overview of Arthrodesis: Indications, Procedure and Recovery Process
Short communication · 14 Mar 2025
Translational Research in Musculoskeletal Regeneration and Repair
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOrthopedic & Muscular System: Current Research
- SubjectOrthopaedics
- BylineArticles whose byline prints “Jun Li”
